Fig. 2From: Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogressionSpleen SUVMax % Δ Post SSA (n = 20, 1 patient prior splenectomy)Back to article page